Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
about
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementInfluence of diet and obesity on COPD development and outcomesMetabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammationMetabolic syndrome and associated factors in people with chronic obstructive pulmonary disease.Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients.Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threatObesity in chronic obstructive pulmonary disease: is fatter really better?Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary diseaseExcessive visceral fat accumulation in advanced chronic obstructive pulmonary disease.Effect of physical training on fat-free mass in patients with chronic obstructive pulmonary disease (COPD)Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease.Impact of overlap syndrome on severity of acute exacerbation of chronic obstructive pulmonary diseaseWhich patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis.Obesity and pulmonary disease: unanswered questions.How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review.Beyond BMI: Obesity and Lung Disease.Nutritional knowledge and desire to change of food preferences among Saudi women in Jeddah, Saudi Arabia.Patterns of fruit and vegetable consumption among Iranian adults: a SuRFNCD-2007 study.Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.Ectopic fat accumulation in patients with COPD: an ECLIPSE substudyOverweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice.The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities.Who consumed 5 or more portions of fruit and vegetables per day in 1986-1987 and in 2000-2001?Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.Metabolic Syndrome as a Factor Affecting Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease.Association between body composition and pulmonary function in elderly people: the Korean Longitudinal Study on Health and Aging.Knowledge of and adherence to fruit and vegetable recommendations and intakes: results of the 2003 health information national trends surveyCOPD patients with and without metabolic syndrome: clinical and functional differences
P2860
Q26799659-A8320E95-D9D4-4677-AC3E-2F43B8E00870Q27026426-F85E4267-7FBC-4186-8B3B-EFC7C893DB85Q33554524-2481EE46-162B-4E55-B6BF-2ADCADC90EEFQ33652576-15F7049B-D151-4B92-8B22-28924E242972Q33802207-405DC116-6A2F-4DF0-9975-98C2198BE616Q33901722-64140B01-50F4-48F1-8B6A-CFB22EC4FCD9Q33967805-C93D692A-8014-4F14-A0BA-CD16E3BC76C7Q34211965-7A703964-562F-42F5-99E1-9575315DFB33Q34228984-2E0560E1-ECBF-4BF1-BBC9-70F041295C19Q34344150-DBEC58A5-FAA6-4274-B415-7370DC8AD403Q34442689-FEA6ECA3-EC5E-4911-9A82-149E1AA45BE2Q35170150-F96483B9-AA81-47D7-BCD7-A37389DFF381Q35308892-412AAEAA-D85B-4790-B6DC-5310224EEDBAQ35824939-5C5BB1E8-991D-49DE-A2C8-C272CC23ABE1Q36330721-1AE728CE-9D55-49FE-96B9-256A3E3FB00EQ36809938-1B5D57BC-E2DA-4991-A14F-611786E0E767Q38014540-93796437-2DAC-4681-A519-A824D318B29AQ38068890-0B9933AA-C561-46AD-83BB-6B1540BC0A6CQ38749690-30E2C6A1-92A5-4960-95E0-C6C1D16AFA74Q39448575-4DB42D6A-2B50-4704-BC3C-D9670E3E6F84Q39586437-380A8ECE-2700-401E-960D-22EF9DAA8E08Q40003892-242EE07B-39C8-4308-8731-3FC741A86F77Q40557048-AB4B523E-AAF3-4F08-9A3F-096BC65CACDCQ42323707-6E4CEB9F-54B9-46BC-9A46-146FEEECE662Q47106747-D16D1423-DF4E-4B15-BC3A-0744B998A29EQ48525384-3FE6B457-CAE5-423B-B865-BAD68BA4C9E3Q50151230-41301466-85BF-4F1F-913A-3C5AC69EE0B7Q50724186-032BB3B7-0BB2-4FB0-9722-4D96F9BEAA6AQ51069537-404EBB7E-ACD9-41D9-ACC0-0B4EE94ED790Q53461683-77418390-AFB9-4BE0-8CDD-13405C00A993Q56897955-6D34B3E4-70A2-4F70-B9CF-BC0F27D4B5CFQ57785897-5033C6E3-F1AC-4A52-A884-B8BE2A1D444D
P2860
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Metabolic and inflammatory pro ...... obstructive pulmonary disease.
@en
Metabolic and inflammatory pro ...... obstructive pulmonary disease.
@nl
type
label
Metabolic and inflammatory pro ...... obstructive pulmonary disease.
@en
Metabolic and inflammatory pro ...... obstructive pulmonary disease.
@nl
prefLabel
Metabolic and inflammatory pro ...... obstructive pulmonary disease.
@en
Metabolic and inflammatory pro ...... obstructive pulmonary disease.
@nl
P2093
P2860
P356
P1476
Metabolic and inflammatory pro ...... obstructive pulmonary disease.
@en
P2093
P2860
P356
10.1177/1479972307087205
P577
2008-01-01T00:00:00Z